| Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia. | |
| | |
MedLine Citation:
|
PMID: 18639689 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Ursodeoxycholic acid is a bile acid that was found to increase bile flow, protect hepatocytes, and dissolve gallstones. PURPOSE: The objective of this study is to review ursodeoxycholic acid in infants and children with extrahepatic biliary atresia. METHODS: We used a statistical analysis of data of records of infants and children having extrahepatic biliary atresia who underwent Kasai portoenterostomy and attended Hepatology Clinic, New Children's Hospital, Cairo University, Egypt, from May 1985 until June 2005. RESULTS: Of 141 infants with extrahepatic biliary atresia, 108 received ursodeoxycholic acid for mean duration +/- SD of 252.6 +/- 544.9 days in a dosage of 20 mg/kg per day. The outcome of infants who did not receive ursodeoxycholic acid and those who did was the following: 8 (24.2%) and 11 (10.18%) had a successful outcome (P = .043), 0 (0%) and 7 (6.4%) improved (P = .148), 25 (75.7%) and 84 (77.7%) had a failed outcome (P = .489), and none vs 5 died (4.6%) (P = .135), respectively. The predictors of successful outcomes were age less than 65 days at portoenterostomy (P = .008) and absence of ursodeoxycholic acid intake (P = .04) with a likelihood of a successful outcome that was 2.8, that associated with ursodeoxycholic acid intake. CONCLUSION: In this cohort of infants with extrahepatic biliary atresia, ursodeoxycholic acid was not shown to be effective, and its use was associated with a plethora of hepatic and extrahepatic complications. |
| | |
Authors:
|
Magd A Kotb |
Related Documents
:
|
8223089 - Transhepatic topical dissolution of gallbladder stones with mtbe and edta. results, sid... 2104069 - Review article: bile acid therapy. 15185309 - Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis. 4031069 - Biosynthesis of bile acids in cerebrotendinous xanthomatosis. relationship of bile acid... 7436359 - Adrenoleukodystrophy: elevated c26 fatty acid in cultured skin fibroblasts. 16143129 - Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic chole... 8304409 - Na(+)-h+ antiporter activity in relation to membrane fatty acid composition and cell pr... 2322019 - Treatment of acute lead intoxication. a quantitative comparison of a number of chelatin... 21383089 - Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechani... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of pediatric surgery Volume: 43 ISSN: 1531-5037 ISO Abbreviation: J. Pediatr. Surg. Publication Date: 2008 Jul |
Date Detail:
|
Created Date: 2008-07-21 Completed Date: 2008-10-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0052631 Medline TA: J Pediatr Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 1321-7 Citation Subset: IM |
Affiliation:
|
Department of Pediatrics, Cairo University, PO Box, 85 El Mokatam, Cairo 11571, Egypt. magdkotb@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bile Ducts, Extrahepatic
/
abnormalities* Biliary Atresia / drug therapy*, surgery Cholagogues and Choleretics / therapeutic use* Female Humans Infant Male Portoenterostomy, Hepatic Retrospective Studies Ursodeoxycholic Acid / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Cholagogues and Choleretics; 128-13-2/Ursodeoxycholic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Preoperative observations and short-term outcome after partial external biliary diversion in 13 pati...
Next Document: Histologic oddities at the porta hepatis in biliary atresia.